Appointment of Joint Broker

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

29 January 2026

Clean Power Hydrogen plc

("CPH2" or the "Company")

Appointment of Joint Broker

CPH2 (LSE:CPH2), which has developed market disrupting and IP-protected Membrane-Free Electrolyser ("MFE") technology for the production of commercial high purity hydrogen and medical-grade oxygen, announces that it has appointed Turner Pope Investments (TPI) Limited ("Turner Pope") as Joint Broker to the Company. 

Commenting, Chief Executive Officer of CPH2, Jon Duffy, said: "We are pleased to add the expertise of Turner Pope to our broking team which will support our strategy to strengthen both our communications with the Stock Market and the marketability of our shares."

Enquiries:

Clean Power Hydrogen plc via Square1 Consulting

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD & Joint Broker 

Neil McDonald +44 131 220 9771

Peter Lynch +44 131 220 9772

Turner Pope Investments (TPI) Limited - Joint Broker

Andy Thacker/Guy McDougall +44 203 657 3657

Square1 Consulting Limited +44 7831 381201

David Bick

Background on CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has a decade of dedicated research and product development experience. This experience has resulted in the creation and proving of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest Levelised Cost of Hydrogen ("LCOH") in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LSE: CPH2.

For more information: https://www.cph2.com